Topical NVN1000 for the Treatment of External Genital and Perianal Warts
Status:
Completed
Trial end date:
2016-10-17
Target enrollment:
Participant gender:
Summary
A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascending Dose Study
Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects with External
Genital Warts and Perianal Warts